189 related articles for article (PubMed ID: 3522225)
1. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria.
de Jongh-Leuvenink J; Bouter AS; Marcelis JH; Schellekens J; Verhoef J
Eur J Clin Microbiol; 1986 Apr; 5(2):148-51. PubMed ID: 2424754
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity.
Oishi K; Koles NL; Guelde G; Pollack M
J Infect Dis; 1992 Jan; 165(1):34-45. PubMed ID: 1727896
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.
Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ
J Infect Dis; 1989 Jan; 159(1):35-42. PubMed ID: 2462603
[TBL] [Abstract][Full Text] [Related]
5. Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.
Vreede RW; Marcelis JH; Verhoef J
Infect Immun; 1986 Jun; 52(3):892-6. PubMed ID: 3519464
[TBL] [Abstract][Full Text] [Related]
6. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
Siber GR; Kania SA; Warren HS
J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
[TBL] [Abstract][Full Text] [Related]
9. Shielding Effect of Escherichia coli O-Antigen Polysaccharide on J5-Induced Cross-Reactive Antibodies.
Rainard P; Repérant-Ferter M; Gitton C; Germon P
mSphere; 2021 Jan; 6(1):. PubMed ID: 33504665
[No Abstract] [Full Text] [Related]
10. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
Mutharia LM; Crockford G; Bogard WC; Hancock RE
Infect Immun; 1984 Sep; 45(3):631-6. PubMed ID: 6381310
[TBL] [Abstract][Full Text] [Related]
11. Specificity and function of monoclonal antibodies reactive with discrete structural elements of bacterial lipopolysaccharide.
Pollack M; Oishi K; Chia J; Evans M; Guelde G; Koles N
Adv Exp Med Biol; 1990; 256():331-40. PubMed ID: 1691578
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.
Salles MF; Mandine E; Zalisz R; Guenounou M; Smets P
J Infect Dis; 1989 Apr; 159(4):641-7. PubMed ID: 2647860
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the opsonic activity of polyclonal and monoclonal antibodies raised against Salmonella minnesota strain R595.
Mehta ND; Wilson BM; Rapson NT; Easmon CS
J Med Microbiol; 1988 Feb; 25(2):85-93. PubMed ID: 2448462
[TBL] [Abstract][Full Text] [Related]
14. Carumonam enhances reactivity of Escherichia coli with mono- and polyclonal antisera to rough Escherichia coli J5.
Overbeek BP; Schellekens JF; Lippe W; Dekker BA; Verhoef J
J Clin Microbiol; 1987 Jun; 25(6):1009-13. PubMed ID: 2439534
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
Nys M; Cloes JM; Demonty J; Joassin L
J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
[TBL] [Abstract][Full Text] [Related]
16. Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli.
Gigliotti F; Shenep JL
J Infect Dis; 1985 Jun; 151(6):1005-11. PubMed ID: 2582064
[TBL] [Abstract][Full Text] [Related]
17. Opsonic effect of monoclonal antibodies against Leptospira interrogans serovar copenhageni.
Takase H; Yanagawa R
Vet Microbiol; 1988 Feb; 16(2):167-80. PubMed ID: 3376416
[TBL] [Abstract][Full Text] [Related]
18. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
[TBL] [Abstract][Full Text] [Related]
20. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
Coughlin RT; Bogard WC
J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
